Back
  1. Home
  2. Profile of Emilie Ansciaux (UMONS)
Profil

Ansciaux Emilie

Main Referenced Co-authors
BURTEA, Carmen  (11)
LAURENT, Sophie  (11)
MULLER, Robert  (11)
Vander elst, Luce  (11)
NONCLERCQ, Denis  (7)
Main Referenced Keywords
Alzheimer's disease (7); molecular imaging (4); amyloid peptide (3); iron oxide nanoparticles (3); neurodegenerative disease (3);
Main Referenced Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (8)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (9)
Chemistry (9)
Pharmacy, pharmacology & toxicology (7)
Immunology & infectious disease (5)
Neurology (5)

Publications (total 11)

The most cited

30 citations (Scopus®)

Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626 https://hdl.handle.net/20.500.12907/16028

Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626
Peer Reviewed verified by ORBi

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (13 June 2014). Un agent de contraste vectorisé contre les plaques amyloïdes et potentiellement capable de franchir la barrière hémato-­encéphalique : vers un diagnostic précoce de la maladie d'Alzheimer par imagerie de résonance magnétique [Paper presentation]. 12ème Réunion Francophone sur la Maladie d'Alzheimer et les syndromes apparentés, Montpellier, France.

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (10 February 2014). A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-­brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging [Poster presentation]. Belgian Peptide Meeting, Ghent, Belgium.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (26 May 2013). A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging [Paper presentation]. 8th Annual Meeting of the European Society of Molecular Imaging, Torino, Italy.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (24 May 2013). USPIO-PHO: a new vectorized contrast agent for early Diagnosis of Alzheimer's disease By molecular imaging [Poster presentation]. 1st Health Institute Day, Mons, Belgium.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (06 March 2013). Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging [Paper presentation]. International Congress Alzheimer's Disease/Parkinson's Disease 2013, Florence, Italy.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (29 January 2013). Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging [Poster presentation]. Journée Scientifique des Doctorants en Sciences biomédicales et pharmaceutiques; New tools and strategies in the identification of pathology-related biomarkers, Mons, Belgium.

Ansciaux, E., Burtea, C., Vander Elst, L., Laurent, S., & Muller, R. (17 June 2012). Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer [Poster presentation]. Doctoriales Franco-Belges, Mont Saint-Aubert, Belgium.

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (22 May 2012). Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer [Poster presentation]. 11ème Réunion sur la Maladie d'Alzheimer et les Symptomes Apparentés, Toulouse, France.

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 October 2011). In vitro and in vivo characterization of several functionalized USPIO derivatives designed for molecular MRI of Alzheimer's disease [Poster presentation]. 28th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Leipzig, Germany.

Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (01 June 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32 (6), 1232-43. doi:10.1016/j.peptides.2011.04.026
Peer Reviewed verified by ORBi

Contact ORBi UMONS